Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Brand-name drug

Auvelity price, strengths & recalls

Brand of bupropion / dextromethorphan (generic)

Pharmacies pay $596.78 for 30 tablets of Auvelity 105 mg / 45 mg extended-release tablet this week, and from $19.82 to $596.78 across its 2 priced strengths and forms. Its official label last changed on August 19, 2026.

Brand
Pharmacies pay$596.78for 30 tablets of 105 mg / 45 mg extended-release tabletNo change in 4 weeks
Fair cash price
$696.80
Strengths
2
Makers
1
Updated
Nov 11

Auvelity price by strength

What pharmacies pay for each strength and form this week (Nov 11, 2026), for 30 tablets. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
105 mg / 45 mg extended-release tablet Brand$19.89$596.78 / 30 tabletsNo change+6.1%
Titration pack Brand$19.82$19.82 / 1 kit

Auvelity vs generic bupropion / dextromethorphan

There is no generic version of Auvelity on the market yet. Its last listed patent or exclusivity runs to November 28, 2043 - generics often follow, though court cases and settlements can move the date either way.

GenericBupropion / dextromethorphan prices

Supply status: shortages & recalls

No shortage reportedChecked Nov 16, 2026
No ongoing recallsNone on record

What did you pay for auvelity? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedAugust 19, 2026
Version18 of 16
EffectiveAug 17, 2026
Read the label

These highlights do not include all the information needed to use AUVELITY safely and effectively. See full prescribing information for AUVELITY. AUVELITY® (dextromethorphan hydrobromide / bupropion hydrochloride) extended-release tablets, for oral use Initial U.S. Approval: 2022<span style="font-weight : bold;" data-mce-style="font-weight: bold;">These highlights do not include all the information needed to use AUVELITY safely and effectively. See full prescribing information for AUVELITY. <br>

This drug has a boxed warning

WARNING: SUICIDAL THOUGHTS AND BEHAVIORS

Antidepressants increased the risk of suicidal thoughts and behaviors in pediatric and young adult patients in short-term studies. Closely monitor all antidepressant-treated patients for clinical worsening, and emergence of suicidal thoughts and behaviors [see Warnings and Precautions (5.1)]. AUVELITY is not approved for use in pediatric patients [see Use in Specific Populations (8.4)].

WARNING: SUICIDAL THOUGHTS AND BEHAVIORS

See full prescribing information for complete boxed warning.

Increased risk of suicidal thoughts and behavior in pediatric and young adult patients taking antidepressants. Closely monitor all antidepressant-treated patients for clinical worsening and emergence of suicidal thoughts and behaviors. AUVELITY is not approved for use in pediatric patients. (5.1, 8.4)

Recent major changes (as listed on the label)

RECENT MAJOR CHANGES

Indications and Usage, Agitation Associated with Dementia Due to Alzheimer's Disease (1.2)------------------------------------------------------------------------- 4/2026

Dosage and Administration, Recommended Dosage for Treatment of Agitation Associated with Dementia Due to Alzheimer's Disease (2.3)----------- 4/2026

Warnings and Precautions, Hyponatremia (5.10)------------------------------ 4/2026

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Application
NDA215430 · Axsome
First approved
August 18, 2022 (4 years ago)
Latest approved change
October 29, 2026
Approved label
PDF, Nov 2, 2026
Generic makers
None on the market
Last patent listed
November 28, 2043
Exclusivity ends
April 30, 2029

Patent dates are what the maker lists with FDA. Generic launch dates are often set by court rulings or settlements instead. Upcoming generics.

Auvelity questions

How much does auvelity cost without insurance?

Pharmacies pay about $596.78 for 30 tablets of auvelity 105 mg / 45 mg extended-release tablet ($19.89 per tablet). A fair cash price - that cost plus a 15% margin and a typical dispensing fee - is about $696.80. If you're quoted much more, check your quote and ask for the pharmacy's cash price.

Is there a generic for Auvelity?

Yes: bupropion / dextromethorphan. Compare bupropion / dextromethorphan prices.

Is auvelity in shortage?

No shortage is reported for auvelity right now. We check the national shortage list every day.

Has auvelity been recalled?

No recalls are on record for auvelity.

When did the auvelity label last change?

The official label was last updated on August 19, 2026 (version 18). See what changed.

Talk about auvelity

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.